Association of sarcopenia with egfr and misclassification of obesity in adults with ckd in the United States

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background and objectives Muscle wasting is common among patients with ESRD, but little is known about differences in muscle mass in persons with CKD before the initiation of dialysis. If sarcopenia was common, it might affect the use of body mass index for diagnosing obesity in people with CKD. Because obesity may be protective in patientswith CKDand ESRD, an accurate understanding of how sarcopenia affects its measurement is crucial. Design, setting, participants, & measurements Differences in body composition across eGFR categories in adult participants of the National Health and Nutrition Examination Survey 1999–2004 who underwent dual-energy x-ray absorptiometry were examined. Obesity defined by dual-energy x-ray absorptiometry versus body mass index and sarcopenia as a contributor to misclassification by body mass index were examined. Results Sarcopenia and sarcopenic obesity were more prevalent among persons with lower eGFR (P trend,0.01 and P trend,0.001, respectively). After multivariable adjustment, the association of sarcopenia with eGFR was U-shaped. Stage 4 CKD was independently associated with sarcopenia among participants $60 years old (adjusted odds ratio, 2.58; 95%confidence interval, 1.02 to 6.51 for eGFR=15–29 comparedwith 60–89 ml/min per 1.73 m2; P for interaction by age=0.02). Underestimation of obesity by body mass index compared with dualenergy x-ray absorptiometry increasedwith lower eGFR (P trend,0.001),was greatest among participants with eGFR=15–29 ml/min per 1.73 m2 (71% obese by dual-energy x-ray absorptiometry versus 41% obese by body mass index), andwas highly likely among obese participantswith sarcopenia (97.7% misclassified as not obese by body mass index). Conclusions Sarcopenia and sarcopenic obesity are highly prevalent among persons with CKD and contribute to poor classification of obesity by body mass index.Measurements of body composition beyond body mass index should be used whenever possible in the CKD population given this clear limitation.

Original languageEnglish (US)
Pages (from-to)2079-2088
Number of pages10
JournalClinical Journal of the American Society of Nephrology
Volume9
Issue number12
DOIs
StatePublished - 2014

Fingerprint

Sarcopenia
Body Mass Index
Obesity
X-Rays
Body Composition
Chronic Kidney Failure
Muscles
Nutrition Surveys
Dialysis
Odds Ratio
Confidence Intervals

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

@article{ee90e768807047dda17a0871a0ab88a1,
title = "Association of sarcopenia with egfr and misclassification of obesity in adults with ckd in the United States",
abstract = "Background and objectives Muscle wasting is common among patients with ESRD, but little is known about differences in muscle mass in persons with CKD before the initiation of dialysis. If sarcopenia was common, it might affect the use of body mass index for diagnosing obesity in people with CKD. Because obesity may be protective in patientswith CKDand ESRD, an accurate understanding of how sarcopenia affects its measurement is crucial. Design, setting, participants, & measurements Differences in body composition across eGFR categories in adult participants of the National Health and Nutrition Examination Survey 1999–2004 who underwent dual-energy x-ray absorptiometry were examined. Obesity defined by dual-energy x-ray absorptiometry versus body mass index and sarcopenia as a contributor to misclassification by body mass index were examined. Results Sarcopenia and sarcopenic obesity were more prevalent among persons with lower eGFR (P trend,0.01 and P trend,0.001, respectively). After multivariable adjustment, the association of sarcopenia with eGFR was U-shaped. Stage 4 CKD was independently associated with sarcopenia among participants $60 years old (adjusted odds ratio, 2.58; 95{\%}confidence interval, 1.02 to 6.51 for eGFR=15–29 comparedwith 60–89 ml/min per 1.73 m2; P for interaction by age=0.02). Underestimation of obesity by body mass index compared with dualenergy x-ray absorptiometry increasedwith lower eGFR (P trend,0.001),was greatest among participants with eGFR=15–29 ml/min per 1.73 m2 (71{\%} obese by dual-energy x-ray absorptiometry versus 41{\%} obese by body mass index), andwas highly likely among obese participantswith sarcopenia (97.7{\%} misclassified as not obese by body mass index). Conclusions Sarcopenia and sarcopenic obesity are highly prevalent among persons with CKD and contribute to poor classification of obesity by body mass index.Measurements of body composition beyond body mass index should be used whenever possible in the CKD population given this clear limitation.",
author = "Deep Sharma and Hawkins, {Meredith A.} and Abramowitz, {Matthew K.}",
year = "2014",
doi = "10.2215/CJN.02140214",
language = "English (US)",
volume = "9",
pages = "2079--2088",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "12",

}

TY - JOUR

T1 - Association of sarcopenia with egfr and misclassification of obesity in adults with ckd in the United States

AU - Sharma, Deep

AU - Hawkins, Meredith A.

AU - Abramowitz, Matthew K.

PY - 2014

Y1 - 2014

N2 - Background and objectives Muscle wasting is common among patients with ESRD, but little is known about differences in muscle mass in persons with CKD before the initiation of dialysis. If sarcopenia was common, it might affect the use of body mass index for diagnosing obesity in people with CKD. Because obesity may be protective in patientswith CKDand ESRD, an accurate understanding of how sarcopenia affects its measurement is crucial. Design, setting, participants, & measurements Differences in body composition across eGFR categories in adult participants of the National Health and Nutrition Examination Survey 1999–2004 who underwent dual-energy x-ray absorptiometry were examined. Obesity defined by dual-energy x-ray absorptiometry versus body mass index and sarcopenia as a contributor to misclassification by body mass index were examined. Results Sarcopenia and sarcopenic obesity were more prevalent among persons with lower eGFR (P trend,0.01 and P trend,0.001, respectively). After multivariable adjustment, the association of sarcopenia with eGFR was U-shaped. Stage 4 CKD was independently associated with sarcopenia among participants $60 years old (adjusted odds ratio, 2.58; 95%confidence interval, 1.02 to 6.51 for eGFR=15–29 comparedwith 60–89 ml/min per 1.73 m2; P for interaction by age=0.02). Underestimation of obesity by body mass index compared with dualenergy x-ray absorptiometry increasedwith lower eGFR (P trend,0.001),was greatest among participants with eGFR=15–29 ml/min per 1.73 m2 (71% obese by dual-energy x-ray absorptiometry versus 41% obese by body mass index), andwas highly likely among obese participantswith sarcopenia (97.7% misclassified as not obese by body mass index). Conclusions Sarcopenia and sarcopenic obesity are highly prevalent among persons with CKD and contribute to poor classification of obesity by body mass index.Measurements of body composition beyond body mass index should be used whenever possible in the CKD population given this clear limitation.

AB - Background and objectives Muscle wasting is common among patients with ESRD, but little is known about differences in muscle mass in persons with CKD before the initiation of dialysis. If sarcopenia was common, it might affect the use of body mass index for diagnosing obesity in people with CKD. Because obesity may be protective in patientswith CKDand ESRD, an accurate understanding of how sarcopenia affects its measurement is crucial. Design, setting, participants, & measurements Differences in body composition across eGFR categories in adult participants of the National Health and Nutrition Examination Survey 1999–2004 who underwent dual-energy x-ray absorptiometry were examined. Obesity defined by dual-energy x-ray absorptiometry versus body mass index and sarcopenia as a contributor to misclassification by body mass index were examined. Results Sarcopenia and sarcopenic obesity were more prevalent among persons with lower eGFR (P trend,0.01 and P trend,0.001, respectively). After multivariable adjustment, the association of sarcopenia with eGFR was U-shaped. Stage 4 CKD was independently associated with sarcopenia among participants $60 years old (adjusted odds ratio, 2.58; 95%confidence interval, 1.02 to 6.51 for eGFR=15–29 comparedwith 60–89 ml/min per 1.73 m2; P for interaction by age=0.02). Underestimation of obesity by body mass index compared with dualenergy x-ray absorptiometry increasedwith lower eGFR (P trend,0.001),was greatest among participants with eGFR=15–29 ml/min per 1.73 m2 (71% obese by dual-energy x-ray absorptiometry versus 41% obese by body mass index), andwas highly likely among obese participantswith sarcopenia (97.7% misclassified as not obese by body mass index). Conclusions Sarcopenia and sarcopenic obesity are highly prevalent among persons with CKD and contribute to poor classification of obesity by body mass index.Measurements of body composition beyond body mass index should be used whenever possible in the CKD population given this clear limitation.

UR - http://www.scopus.com/inward/record.url?scp=84923865061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923865061&partnerID=8YFLogxK

U2 - 10.2215/CJN.02140214

DO - 10.2215/CJN.02140214

M3 - Article

C2 - 25392147

AN - SCOPUS:84923865061

VL - 9

SP - 2079

EP - 2088

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

SN - 1555-9041

IS - 12

ER -